The global head and neck cancer diagnostics market was valued at USD 6.19 billion in 2014 and is projected to reach USD 12.6 billion by 2020, growing at a CAGR of 12.67% during the forecast period. Overall, head and neck cancers account for more than 550,000 cases annually (roughly 3-5 % of all cancer incidences) all over the world. Generally, males are affected significantly more than females with a ratio ranging from 2:1 to 4:1. The market for head and neck cancer diagnostics is expected to i Más
